Skip to content

Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate

C29H32ClN9O5 — CID 139208065

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate
SMILESCOC(=O)Nc1ccc2c(c1)N[C@@H](CO)[C@@H](CO)CCC[C@H](NC(=O)/C=C/c1cc(Cl)ccc1-n1cnnn1)c1ncc-2[nH]1
InChIInChI=1S/C29H32ClN9O5/c1-44-29(43)33-20-7-8-21-23(12-20)34-25(15-41)18(14-40)3-2-4-22(28-31-13-24(21)36-28)35-27(42)10-5-17-11-19(30)6-9-26(17)39-16-32-37-38-39/h5-13,16,18,22,25,34,40-41H,2-4,14-15H2,1H3,(H,31,36)(H,33,43)(H,35,42)/b10-5+/t18-,22+,25+/m1/s1
InChIKeyGSUOHWDZBHDFTM-PMQQWPQESA-N
MW622.09 g/mol
LogP3.32
Rot. Bonds7

About Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate

Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate (PubChem CID 139208065) has the molecular formula C29H32ClN9O5 and a molecular weight of 622.09 g/mol. Its IUPAC name is methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate.

Molecular Properties

Compound NameMethyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate
PubChem CID139208065
Molecular FormulaC29H32ClN9O5
Molecular Weight622.09 g/mol
Exact Mass621.22
IUPAC Namemethyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate
SMILESCOC(=O)Nc1ccc2c(c1)N[C@@H](CO)[C@@H](CO)CCC[C@H](NC(=O)/C=C/c1cc(Cl)ccc1-n1cnnn1)c1ncc-2[nH]1
InChIInChI=1S/C29H32ClN9O5/c1-44-29(43)33-20-7-8-21-23(12-20)34-25(15-41)18(14-40)3-2-4-22(28-31-13-24(21)36-28)35-27(42)10-5-17-11-19(30)6-9-26(17)39-16-32-37-38-39/h5-13,16,18,22,25,34,40-41H,2-4,14-15H2,1H3,(H,31,36)(H,33,43)(H,35,42)/b10-5+/t18-,22+,25+/m1/s1
InChIKeyGSUOHWDZBHDFTM-PMQQWPQESA-N
XLogP3.32
TPSA192.20 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms44
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500622.09
LogP ≤ 53.32
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate?
The IUPAC name of Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate (CID 139208065) is methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate.
What is the SMILES notation for Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate?
The canonical SMILES for Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate is COC(=O)Nc1ccc2c(c1)N[C@@H](CO)[C@@H](CO)CCC[C@H](NC(=O)/C=C/c1cc(Cl)ccc1-n1cnnn1)c1ncc-2[nH]1.
What is the InChIKey of Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate?
The InChIKey is GSUOHWDZBHDFTM-PMQQWPQESA-N. The full InChI is InChI=1S/C29H32ClN9O5/c1-44-29(43)33-20-7-8-21-23(12-20)34-25(15-41)18(14-40)3-2-4-22(28-31-13-24(21)36-28)35-27(42)10-5-17-11-19(30)6-9-26(17)39-16-32-37-38-39/h5-13,16,18,22,25,34,40-41H,2-4,14-15H2,1H3,(H,31,36)(H,33,43)(H,35,42)/b10-5+/t18-,22+,25+/m1/s1.
What are the key properties of Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate?
Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate has a molecular weight of 622.09 g/mol, XLogP of 3.32, 7 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for Methyl N-[(9R,10S,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9,10-bis(hydroxymethyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate is sourced from PubChem (CID 139208065), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.